Published in J Immunol Methods on March 10, 1994
RNA-protein interactions in the human RNase MRP ribonucleoprotein complex. RNA (1999) 1.41
cDNA cloning and characterization of the human U3 small nucleolar ribonucleoprotein complex-associated 55-kilodalton protein. Mol Cell Biol (1998) 1.07
Interaction of the U3-55k protein with U3 snoRNA is mediated by the box B/C motif of U3 and the WD repeats of U3-55k. Nucleic Acids Res (2000) 1.01
Identification of a novel cis-acting RNA element involved in nuclear export of hY RNAs. RNA (2001) 1.01
Differential association of protein subunits with the human RNase MRP and RNase P complexes. RNA (2006) 1.00
Basic domains target protein subunits of the RNase MRP complex to the nucleolus independently of complex association. Mol Biol Cell (2001) 0.89
Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations. Clin Exp Immunol (2002) 0.83
Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet (1985) 10.67
Shifts in selective visual attention: towards the underlying neural circuitry. Hum Neurobiol (1985) 4.78
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
Shoulder disorders in general practice: prognostic indicators of outcome. Br J Gen Pract (1996) 3.46
International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) Am J Clin Pathol (1999) 3.31
Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum (1997) 3.29
Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies. J Immunol (1989) 3.13
Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum (1999) 2.66
The interpretation of structure from motion. Proc R Soc Lond B Biol Sci (1979) 2.23
Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis. Arthritis Rheum (1995) 2.09
Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy. Clin Exp Immunol (1997) 2.05
Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) Br J Rheumatol (1998) 1.91
A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum (1999) 1.85
Visual routines. Cognition (1984) 1.76
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut (2005) 1.73
[Chronic fatigue syndrome--a defined unity?]. Ugeskr Laeger (1994) 1.71
High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr (2001) 1.65
Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int (2000) 1.64
Anti-phospholipid antibodies in patients with Plasmodium falciparum malaria. Immunology (1993) 1.64
Patients with anticentromere antibodies, clinical features, diagnoses and evolution. Br J Rheumatol (1993) 1.64
Granulocyte-specific antinuclear antibodies. Possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis. Allergy (1980) 1.59
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
Aligning pictorial descriptions: an approach to object recognition. Cognition (1989) 1.55
Meta-analysis of second-line antirheumatic drugs: sample size bias and uncertain benefit. J Clin Epidemiol (1992) 1.54
Bilateral angle-closure glaucoma in association with the acquired immune deficiency syndrome. Am J Ophthalmol (1986) 1.54
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
Factors affecting survival in juvenile systemic sclerosis. Rheumatology (Oxford) (2008) 1.49
Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes (1994) 1.48
Treatment of chlamydial urethritis in men and Chlamydia trachomatis-positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Sex Transm Dis (1983) 1.45
Anti-neutrophil cytoplasmic antibodies in chronic inflammatory bowel disease. Prevalence and diagnostic role. Scand J Gastroenterol (1995) 1.45
[Intra-articular glucocorticoid injections in joint diseases]. Ugeskr Laeger (1999) 1.44
Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens. Eur J Immunol (1985) 1.44
Scintimetric assessment of synovitis activity during treatment with disease modifying antirheumatic drugs. Ann Rheum Dis (1988) 1.41
Directional selectivity and its use in early visual processing. Proc R Soc Lond B Biol Sci (1981) 1.41
Trimethoprim-sulphamethoxazole in gonorrhoea. Acta Derm Venereol (1971) 1.39
Adenoviral heterogeneous nuclear RNA is associated with host cell proteins. Eur J Biochem (1981) 1.36
Organ specific antibodies in Addison's disease. Acta Med Scand Suppl (1966) 1.32
Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol (1977) 1.28
Spatial context in recognition. Perception (1996) 1.25
The diversity of perinuclear antineutrophil cytoplasmic antibodies (pANCA) antigens. Clin Exp Immunol (1995) 1.25
Cellular hypersensitivity in Hashimoto's thyroiditis. Specific action of thyroid extract upon the migration of leucocytes in vitro. Acta Med Scand (1968) 1.23
Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J (Clin Res Ed) (1987) 1.22
On autonomy and participation in rehabilitation. Disabil Rehabil (2002) 1.21
Source of amino acids used for protein synthesis in HeLa cells. Eur J Biochem (1974) 1.16
Structure and function of La and Ro RNPs. Mol Biol Rep (1990) 1.15
Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol (1999) 1.15
Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem (1995) 1.13
Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis. Scand J Respir Dis (1975) 1.13
Quantitative determination of immunoglobulins in nasal secretion. Int Arch Allergy Appl Immunol (1975) 1.12
Immunological studies in two children with recurrent parotitis. Acta Paediatr Scand (1983) 1.10
Antinuclear factors in sera from healthy blood donors. Acta Pathol Microbiol Scand C (1976) 1.09
Organ antibodies in Sjögren's syndrome. Acta Allergol (1965) 1.09
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08
[Chronic fatigue syndrome--a controlled cross-sectional study]. Ugeskr Laeger (1994) 1.08
Characterization of cis-acting signals for nuclear import and retention of the La (SS-B) autoantigen. Exp Cell Res (1996) 1.08
Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis. Ann Rheum Dis (1974) 1.06
Anti-neutrophil cytoplasm antibodies 1988. Lancet (1988) 1.06
Organ antibodies in disseminated lupus erythematosus. Acta Med Scand (1965) 1.06
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres. Ann Rheum Dis (2011) 1.05
A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol (1998) 1.05
Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea (1997) 1.05
High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol (1994) 1.04
Interaction of the La (SS-B) autoantigen with small ribosomal subunits. Eur J Biochem (1996) 1.04
Relationship between extracellular amino acids and protein synthesis in vitro in the rat pancreas. Eur J Biochem (1972) 1.04
Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol (1998) 1.04
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) (2003) 1.04
Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice? Clin Exp Immunol (1995) 1.03
Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Kidney Int (1998) 1.03
Clinical synovitis and radiological lesions in rheumatoid arthritis. A prospective study of 25 patients during treatment with remission-inducing drugs. Scand J Rheumatol (1983) 1.03
Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor. Scand J Rheumatol (1979) 1.03
A clinical study of 32 patients with oral discoid lupus erythematosus. Int J Oral Surg (1978) 1.02
Multicenter validation of recombinant, natural and synthetic antigens used in a single multiparameter assay for the detection of specific anti-nuclear autoantibodies in connective tissue disorders. Clin Exp Rheumatol (1999) 1.02
Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol (2004) 1.02
A supplemental labeling system for topical medications. Am J Ophthalmol (1987) 1.01
High-affinity binding sites for prostaglandin E on human lymphocytes. Cell Immunol (1979) 1.01
Humoral and cellular immunity in sarcoidosis. Acta Med Scand (1978) 1.01
HLA type as a predictor of mixed connective tissue disease differentiation. Ten-year clinical and immunogenetic followup of 46 patients. Arthritis Rheum (1995) 1.00
Rapid screening assay for anti-GBM antibody and ANCAs; an important tool for the differential diagnosis of pulmonary renal syndromes. Nephrol Dial Transplant (1997) 1.00
Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun (1988) 0.99
Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. J Rheumatol (2001) 0.99
Granulocyte specific antinuclear antibodies in ulcerative colitis. Aid in differential diagnosis of inflammatory bowel disease. Acta Pathol Microbiol Immunol Scand C (1983) 0.99
Demonstration of electrophoretic heterogeneity of serum beta 2-microglobulin in systemic lupus erythematosus and rheumatoid arthritis: evidence against autoantibodies to beta 2-microglobulin. Scand J Immunol (1979) 0.98
Indirect immunofluorescence examination for IgG-ANCA in sera submitted for the 1st international workshop on ANCA, 1988. APMIS Suppl (1989) 0.98
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol (1998) 0.98
Multicenter evaluation study on a new HEp2 ANA screening enzyme immune assay. J Autoimmun (1999) 0.97
Restrictions among heavy and light chain determinants of granulocyte-specific antinuclear factors. Immunology (1972) 0.97